These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD, Saeed MF, Johnson BH, Thompson EB. Cancer Res; 1998 Aug 15; 58(16):3684-93. PubMed ID: 9721879 [Abstract] [Full Text] [Related]
9. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X, Zhou CY, Li Q, Gao J, Zhu YP, Gu L, Ma ZG. Biomed Environ Sci; 2013 May 15; 26(5):371-81. PubMed ID: 23611130 [Abstract] [Full Text] [Related]
12. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. Chen Z, Lan X, Wu D, Sunkel B, Ye Z, Huang J, Liu Z, Clinton SK, Jin VX, Wang Q. Nat Commun; 2015 Sep 16; 6():8323. PubMed ID: 26374485 [Abstract] [Full Text] [Related]
14. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6. Visser K, Smith C, Louw A. Endocrinology; 2010 Nov 16; 151(11):5279-93. PubMed ID: 20881254 [Abstract] [Full Text] [Related]
15. A New Indole Derivative, LWX-473, Overcomes Glucocorticoid Resistance in Jurkat Cells by Activating Mediators of Apoptosis. Song J, Yang K, Gajendran B, Varier KM, Li W, Liu Q, Rao Q, Hang Y, Shen X, Liu S, Huang L, Xu M, Li Y. Front Biosci (Landmark Ed); 2024 Apr 23; 29(4):163. PubMed ID: 38682179 [Abstract] [Full Text] [Related]
16. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. Evangelisti C, Cappellini A, Oliveira M, Fragoso R, Barata JT, Bertaina A, Locatelli F, Simioni C, Neri LM, Chiarini F, Lonetti A, Buontempo F, Orsini E, Pession A, Manzoli L, Martelli AM, Evangelisti C. J Cell Physiol; 2018 Mar 23; 233(3):1796-1811. PubMed ID: 28777460 [Abstract] [Full Text] [Related]
17. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Thomas AL, Coarfa C, Qian J, Wilkerson JJ, Rajapakshe K, Krett NL, Gunaratne PH, Rosen ST. Nucl Recept Signal; 2015 Mar 23; 13():e006. PubMed ID: 26715915 [Abstract] [Full Text] [Related]
18. A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma. Reber LL, Daubeuf F, Plantinga M, De Cauwer L, Gerlo S, Waelput W, Van Calenbergh S, Tavernier J, Haegeman G, Lambrecht BN, Frossard N, De Bosscher K. J Immunol; 2012 Apr 01; 188(7):3478-87. PubMed ID: 22393156 [Abstract] [Full Text] [Related]
19. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma. Patel GC, Millar JC, Clark AF. Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):1967-1978. PubMed ID: 31050723 [Abstract] [Full Text] [Related]
20. Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. Pazdrak K, Moon Y, Straub C, Stafford S, Kurosky A. Apoptosis; 2016 Apr 01; 21(4):421-31. PubMed ID: 26880402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]